Document is current

Any future updates will be listed below

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-017-3846-8

Published Online: 2017-12-04

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark